Search results for “Anti-IL-6” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 517 patents, we discovered top 48 key players by total patent application. Chugai Pharmaceutical Co., Ltd., Vitaeris, Inc., Janssen Biotech are dominant in this area. They take 52.80% of the total patent filing.
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 177
STARTUP
Vitaeris, Inc.
British Columbia, Canada
Patent: 57
Janssen Biotech
Belgium
Patent: 39
AlderBio Holdings LLC
Nevada, United States
Patent: 37
Centocor, Inc.
Pennsylvania, United States
Patent: 33
Applied Molecular Evolution, Inc.
California, United States
Patent: 31
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 21
MedImmune LLC
Louisiana, United States
Patent: 18
Novimmune SA
Genève, Switzerland
Patent: 17
Lundbeck Seattle BioPharmaceuticals, Inc.
Washington, United States
Patent: 16
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 57 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Vitaeris, Inc.
British Columbia, Canada
Patent: 57
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing Vitaeris, Inc., Chugai Pharmaceutical Co., Ltd., AlderBio Holdings LLC take 47.83% of patent filing during this period.
STARTUP
Vitaeris, Inc.
British Columbia, Canada
Patent: 5
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 4
AlderBio Holdings LLC
Nevada, United States
Patent: 2
Kodiak Sciences, Inc.
California, United States
Patent: 2
National University of Singapore
Central Region, Singapore
Patent: 2
Beijing Huizhiheyuan Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Maeda Kensetsu Kogyo KK
Saga-ken, Japan
Patent: 1
Fresenius Kabi Deutschland GmbH
Hessen, Germany
Patent: 1
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 1
Chengdu Excellent Medical Scientific Co.,Ltd
Sichuan Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents in last 5 years, we discover 8 new entrants. Kodiak Sciences, Inc., National University of Singapore, Chengdu Excellent Medical Scientific Co.,Ltd are the most active new entrants in this area.
Kodiak Sciences, Inc.
California, United States
Patent: 2
National University of Singapore
Central Region, Singapore
Patent: 2
Chengdu Excellent Medical Scientific Co.,Ltd
Sichuan Sheng, China
Patent: 1
Beijing Huizhiheyuan Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Hyogo College of Medicine
Hokkaido, Japan
Patent: 1
Shandong First Medical University
Shandong Sheng, China
Patent: 1
Cedars-Sinai Medical Center
California, United States
Patent: 1
Fresenius Kabi Deutschland GmbH
Hessen, Germany
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 74 patents, we discovered top 11 universities and scientific research institutions by total patent application. Shinshu University, Keio University, Fukuoka University are dominant in this area. They take 109.46% of the total patent filing.
Shinshu University
Nagano-ken, Japan
Patent: 18
Keio University
Tokyo-to, Japan
Patent: 17
Fukuoka University
Fukuoka-ken, Japan
Patent: 10
Carnegie Mellon University
Pennsylvania, United States
Patent: 6
Osaka University
Osaka-fu, Japan
Patent: 3
Chiba University
Chiba-ken, Japan
Patent: 3
National University of Singapore
Central Region, Singapore
Patent: 2
Nagoya University
Aichi-ken, Japan
Patent: 2
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 1
University of Charles
Czechia
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: